V
Vor Biopharma D
D
VOR
0.77000
USD
-0.03
(-3.75%)
Market Open
Volume
2,662
EPS
-2
Div Yield
-
P/E
-0
Market Cap
52,878,681
Novo Nordisk Surges in Profit and Sales
6 months ago
Stocks news More
Title: Vor Biopharma
Sector: Healthcare
Industry: Biotechnology
Vor Biopharma Inc is a clinical stage cell therapy company. It combines a novel patient engineering approach with targeted therapies to provide a solution for patients suffering from hematological malignancies. The company's products include VOR33.